Merck (MRK) Share-based Compensation (2009 - 2026)

Merck (MRK) has reported Share-based Compensation for 18 consecutive years, with $298.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 37.96% year-over-year to $298.0 million in Q2 2026; TTM through Jun 2026 was $892.0 million, a 12.48% increase from a year earlier, with the FY2025 full-year figure at $820.0 million, up 7.75% from the prior year.
• Share-based Compensation was $298.0 million for Q2 2026 at Merck, up from $185.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $298.0 million in Q2 2026 and troughed at $120.0 million in Q1 2022.
• A 5-year average of $180.6 million and a median of $180.5 million in 2024 frame the typical range for Share-based Compensation.
• The widest YoY moves for Share-based Compensation: up 37.96% in 2026, down 5.13% in 2026.
• Over 5 years, Share-based Compensation stood at $145.0 million in 2022, then rose by 15.17% to $167.0 million in 2023, then grew by 11.98% to $187.0 million in 2024, then climbed by 9.63% to $205.0 million in 2025, then surged by 45.37% to $298.0 million in 2026.
• The last three Share-based Compensation figures came in at $298.0 million (Q2 2026), $185.0 million (Q1 2026), and $205.0 million (Q4 2025), per Business Quant data.